Costache, D.O.; Feroiu, O.; Ghilencea, A.; Georgescu, M.; Căruntu, A.; Căruntu, C.; Țiplica, S.G.; Jinga, M.; Costache, R.S.
Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis. Int. J. Mol. Sci. 2022, 23, 5198.
https://doi.org/10.3390/ijms23095198
AMA Style
Costache DO, Feroiu O, Ghilencea A, Georgescu M, Căruntu A, Căruntu C, Țiplica SG, Jinga M, Costache RS.
Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis. International Journal of Molecular Sciences. 2022; 23(9):5198.
https://doi.org/10.3390/ijms23095198
Chicago/Turabian Style
Costache, Daniel Octavian, Oana Feroiu, Adelina Ghilencea, Mihaela Georgescu, Ana Căruntu, Constantin Căruntu, Sorin George Țiplica, Mariana Jinga, and Raluca Simona Costache.
2022. "Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis" International Journal of Molecular Sciences 23, no. 9: 5198.
https://doi.org/10.3390/ijms23095198
APA Style
Costache, D. O., Feroiu, O., Ghilencea, A., Georgescu, M., Căruntu, A., Căruntu, C., Țiplica, S. G., Jinga, M., & Costache, R. S.
(2022). Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis. International Journal of Molecular Sciences, 23(9), 5198.
https://doi.org/10.3390/ijms23095198
